课题基金 / 基金详情

Electrophysiological biomarkers of sleep and cognition in Dup15q syndrome

Electrophysiological biomarkers of sleep and cognition in Dup15q syndrome
Dup15q 综合征睡眠和认知的电生理生物标志物
批准号:
9810069
负责人:
Shafali Spurling Jeste
金额:
$22.46万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-05 至 2021-07-31

项目摘要

项目成果

Shafali Spurling Jeste的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 15q11.3-21.1(Dup15q综合征)的重复对智力残疾(ID)、自闭症具有高度渗透性 谱系障碍和癫痫(Finucane等人,2016)。该区域的几个基因,特别是UBE3A 和一组GABAA受体基因,对神经发育至关重要,扰乱突触蛋白 合成和降解以及抑制性神经传递。在之前的一项研究中,我们发现了一个 这种综合征的电生理生物标记物定义为β带振荡增加,可能反映 异常的GABA能神经传递(Frohlich等人,2016)。当我们进一步探索这一特性时 ,我们发现这些儿童的睡眠生理严重异常,严重 慢波睡眠减弱,睡眠纺锤体密度降低。健康的睡眠生理学是必要的 强健的认知发展,从早期婴儿期到成年期,(den Bakker等人,2018年;Fogel&Smith, 2011年;Hahn等人,2018年;Tham,Schneider,&Broekman,2017),并且有广泛的证据表明 神经发育障碍的生理性睡眠障碍(Gruber&Wise,2016;Kose,Yilmaz, Ocakoglu和Ozbaran,2017;Tessier等人,2015)。我们假设睡眠生理学异常直接 破坏Dup15q综合征的认知发展,并可能作为可量化和可修改的 药物甚至行为干预的目标。通过与Dup15q联盟的伙伴关系 (患者权益倡导组织)和我们的加州大学洛杉矶分校智力和发育障碍研究中心(IDDRC), 我们建议对Dup15q综合征的睡眠电生理学和认知进行全面的研究。我们会 收集之前记录的全国Dup15q综合征儿童的过夜临床脑电 并将这些脑电与非综合征型儿童和典型发育不良儿童的脑电进行比较。我们会问 睡眠生理,特别是(1)纺锤波密度,(2)慢波睡眠百分比,(3)峰值百分比 慢波睡眠和(4)睡眠阶段1和2的绝对β功率区分Dup15q综合征和 这些比较组以及这些变量是否与认知和适应技能有关。这一领域 神经发育障碍严重缺乏可量化的电生理生物标记物 疾病机制,睡眠脑电可能是一个强大的生物标志物,揭示了病因 认知障碍,同时也是临床试验的替代终点,特别是Dup15q 综合症。此外,我们已经开发的管道,从建立远程临床脑电图库到 执行半自动睡眠脑电信号处理可以为其他生物标志物研究提供信息 非综合征型的ID。
英文摘要
Project Abstract Duplications of 15q11.3-21.1 (Dup15q syndrome) are highly penetrant for intellectual disability (ID), autism spectrum disorder (ASD) and epilepsy (Finucane et al., 2016). Several genes in the region, particularly UBE3A and a cluster of GABAA receptor genes, are critical for neural development, disrupting synaptic protein synthesis and degradation as well as inhibitory neurotransmission. In a previous study, we identified an electrophysiological biomarker of this syndrome defined by increased beta band oscillations that likely reflect aberrant GABAergic neurotransmission (Frohlich et al., 2016). As we further explored properties of this biomarker, we discovered that the sleep physiology in these children is profoundly abnormal, with grossly attenuated slow wave sleep and reduced sleep spindle density. Healthy sleep physiology is necessary for robust cognitive development, from early infancy through adulthood, (den Bakker et al., 2018; Fogel & Smith, 2011; Hahn et al., 2018; Tham, Schneider, & Broekman, 2017), and there is extensive evidence of physiological sleep impairment in neurodevelopmental disorders (Gruber & Wise, 2016; Kose, Yilmaz, Ocakoglu, & Ozbaran, 2017; Tessier et al., 2015). We hypothesize that abnormal sleep physiology directly undermines cognitive development in Dup15q syndrome and may serve as a quantifiable and modifiable target for pharmacological or even behavioral interventions. Through a partnership with the Dup15q Alliance (patient advocacy group) and our UCLA Intellectual and Developmental Disabilities Research Center (IDDRC), we propose a comprehensive study of sleep electrophysiology and cognition in Dup15q syndrome. We will collect previously recorded overnight clinical EEG’s from children with Dup15q syndrome across the country and compare these EEG’s to those of children with nonsyndromic ID and typical development. We will ask whether sleep physiology, specifically (1) spindle density, (2) percent slow wave sleep, (3) percent spikes in slow wave sleep and (4) absolute beta power in stage 1 and 2 of sleep differentiates Dup15q syndrome from these comparison groups and whether these variables relate to cognition and adaptive skills. The field of neurodevelopmental disorders has sorely lacked quantifiable electrophysiological biomarkers that relate to disease mechanisms, and sleep EEG may represent a robust biomarker that sheds light on the etiology of cognitive impairment while also serving as a surrogate endpoint in clinical trials, particularly for Dup15q syndrome. Moreover, the pipeline that we have developed, from building a remote clinical EEG repository to performing semi-automated sleep EEG signal processing can inform other biomarker studies in syndromic and nonsyndromic forms of ID.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
  • 批准号:
    10452439
  • 项目类别:
  • 资助金额:
    $85.51万
  • 财政年份:
    2021
  • 负责人:
    Shafali Spurling Jeste
  • 依托单位:
Toward Scalable Biomarker-Based Prediction of ASD in High-Risk Infants
  • 批准号:
    10475316
  • 项目类别:
  • 资助金额:
    $74.94万
  • 财政年份:
    2021
  • 负责人:
    Shafali Spurling Jeste
  • 依托单位:
Toward scalable biomarker-based prediction of ASD in high-risk infants
Mechanisms of Change with Early Intervention in Tuberous Sclerosis Complex
  • 批准号:
    10380038
  • 项目类别:
  • 资助金额:
    $48.42万
  • 财政年份:
    2017
  • 负责人:
    Shafali Spurling Jeste
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: